APONTIS PHARMA AG (APPH.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:APPH - DE000A3CMGM5 - Common Stock
11 EUR
0 (0%)
Taking everything into account, APPH scores 5 out of 10 in our fundamental rating. APPH was compared to 55 industry peers in the Pharmaceuticals industry. While APPH has a great health rating, there are worries on its profitability. APPH has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
- APPH had positive earnings in the past year.
- APPH had a negative operating cash flow in the past year.
- The reported net income has been mixed in the past 5 years: APPH reported negative net income in multiple years.
- In multiple years APPH reported negative operating cash flow during the last 5 years.
1.2 Ratios
- APPH has a Return On Assets of 1.70%. This is in the lower half of the industry: APPH underperforms 60.71% of its industry peers.
- APPH has a worse Return On Equity (2.34%) than 60.71% of its industry peers.
- With a Return On Invested Capital value of 2.01%, APPH is not doing good in the industry: 64.29% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.7% | ||
| ROE | 2.34% | ||
| ROIC | 2.01% |
ROA(3y)-4.37%
ROA(5y)-3.69%
ROE(3y)-9.26%
ROE(5y)-12.74%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- With a Profit Margin value of 1.55%, APPH perfoms like the industry average, outperforming 41.07% of the companies in the same industry.
- Looking at the Operating Margin, with a value of 2.60%, APPH is doing worse than 64.29% of the companies in the same industry.
- APPH's Operating Margin has declined in the last couple of years.
- The Gross Margin of APPH (57.16%) is worse than 67.86% of its industry peers.
- APPH's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.6% | ||
| PM (TTM) | 1.55% | ||
| GM | 57.16% |
OM growth 3Y-32.83%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.69%
GM growth 5Y-4.61%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so APPH is destroying value.
- The number of shares outstanding for APPH remains at a similar level compared to 1 year ago.
- Compared to 5 years ago, APPH has less shares outstanding
- There is no outstanding debt for APPH. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- APPH has an Altman-Z score of 6.01. This indicates that APPH is financially healthy and has little risk of bankruptcy at the moment.
- APPH has a better Altman-Z score (6.01) than 87.50% of its industry peers.
- There is no outstanding debt for APPH. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 6.01 |
ROIC/WACC0.28
WACC7.19%
2.3 Liquidity
- APPH has a Current Ratio of 6.82. This indicates that APPH is financially healthy and has no problem in meeting its short term obligations.
- The Current ratio of APPH (6.82) is better than 98.21% of its industry peers.
- APPH has a Quick Ratio of 4.86. This indicates that APPH is financially healthy and has no problem in meeting its short term obligations.
- APPH has a Quick ratio of 4.86. This is amongst the best in the industry. APPH outperforms 98.21% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 6.82 | ||
| Quick Ratio | 4.86 |
3. Growth
3.1 Past
- APPH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 106.98%, which is quite impressive.
- Looking at the last year, APPH shows a very strong growth in Revenue. The Revenue has grown by 31.12%.
- The Revenue has been growing slightly by 3.89% on average over the past years.
EPS 1Y (TTM)106.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-12.5%
Revenue 1Y (TTM)31.12%
Revenue growth 3Y-1.8%
Revenue growth 5Y3.89%
Sales Q2Q%14.55%
3.2 Future
- APPH is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 128.83% yearly.
- The Revenue is expected to grow by 15.31% on average over the next years. This is quite good.
EPS Next Y393.69%
EPS Next 2Y194.54%
EPS Next 3Y128.83%
EPS Next 5YN/A
Revenue Next Year21.53%
Revenue Next 2Y20.18%
Revenue Next 3Y18.69%
Revenue Next 5Y15.31%
3.3 Evolution
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 122.22, the valuation of APPH can be described as expensive.
- 67.86% of the companies in the same industry are cheaper than APPH, based on the Price/Earnings ratio.
- The average S&P500 Price/Earnings ratio is at 27.25. APPH is valued rather expensively when compared to this.
- Based on the Price/Forward Earnings ratio of 11.20, the valuation of APPH can be described as reasonable.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of APPH indicates a somewhat cheap valuation: APPH is cheaper than 75.00% of the companies listed in the same industry.
- APPH's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 25.98.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 122.22 | ||
| Fwd PE | 11.2 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, APPH is valued a bit more expensive than the industry average as 69.64% of the companies are valued more cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 30.66 |
4.3 Compensation for Growth
- APPH's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- A more expensive valuation may be justified as APPH's earnings are expected to grow with 128.83% in the coming years.
PEG (NY)0.31
PEG (5Y)N/A
EPS Next 2Y194.54%
EPS Next 3Y128.83%
5. Dividend
5.1 Amount
- APPH does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
APONTIS PHARMA AG / APPH.DE FAQ
Can you provide the ChartMill fundamental rating for APONTIS PHARMA AG?
ChartMill assigns a fundamental rating of 5 / 10 to APPH.DE.
Can you provide the valuation status for APONTIS PHARMA AG?
ChartMill assigns a valuation rating of 4 / 10 to APONTIS PHARMA AG (APPH.DE). This can be considered as Fairly Valued.
What is the profitability of APPH stock?
APONTIS PHARMA AG (APPH.DE) has a profitability rating of 1 / 10.
What is the expected EPS growth for APONTIS PHARMA AG (APPH.DE) stock?
The Earnings per Share (EPS) of APONTIS PHARMA AG (APPH.DE) is expected to grow by 393.69% in the next year.